MedPath

TPE in Septic Patients and Influence on Organ Failure

Not Applicable
Conditions
Multiple Organ Failure
Interventions
Device: Therapeutic Plasma Exchange (TPE)
Registration Number
NCT02906345
Lead Sponsor
University of Rostock
Brief Summary

Therapeutic plasma exchange (TPE) should used for patients with septic shock in a controlled, prospective study focusing on the organ functions of the patients.

Detailed Description

Therapeutic plasma exchange (TPE) should used for patients with septic shock in a controlled, prospective study.

Investigators will study three groups:

1. untreated control group;

2. TPE group, plasma separation carried out by filtration;

3. TPE group, plasma separation carried out by centrifugation.

All treated patients should treated two (minimal) to five times by TPE, depending on the need of norephinephrine for the therapy. For each session 40 ml/kg body weight plasma should be exchange. Fluid resuscitation will be done with fresh frozen plasma. The study will focusing on the organ functions of the patients, especially liver-, kidney- and nervous function and also displayed in the SOFA score on study days 3 and 7.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
30
Inclusion Criteria
  • Septic shock, beginning of shock < 24 hours
Exclusion Criteria
  • Participation in an another clinical trial within the last 30 days
  • Participation in this study at an earlier date
  • Simultaneous participation in another clinical trial
  • Pregnancy
  • Unpredictable Bleeding (over 2 erythrocyte concentrates daily)
  • Polyneuropathy (known before the beginning of sepsis)

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
TPE-CentrifugationTherapeutic Plasma Exchange (TPE)Patients with septic shock, therapeutic plasma exchange, plasma separation using a centrifuge (Fresenius COM-TEC, PL1 Erythrozytapherese/Plasmabeutel Set) BMC standard treatment
TPE-Filtration GroupTherapeutic Plasma Exchange (TPE)Patients with septic shock, therapeutic plasma exchange, plasma separation using a filter (Fresenius MultiFiltrate, Kit 16 MPS P2 dry), BMC standard treatment
Primary Outcome Measures
NameTimeMethod
SOFA score ≥ 2 Punkteday 7

SOFA: Sepsis-related Organ Failure Assessment score

Secondary Outcome Measures
NameTimeMethod
28-day survivalday 28

Observation time 28 days

Hospital survival1 year

Leave the patients the hospital?

Trial Locations

Locations (1)

Intensive Care Units PIT 1+2, University Hospital Rostock

🇩🇪

Rostock, Germany

© Copyright 2025. All Rights Reserved by MedPath